Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185)

:2185

2185

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H

RESEARCH TOOLSreports

Want to see HK:2185 full AI Analyst Report?

Compare Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (2185) vs. Competitors

0 Followers

Comparison Results

2185

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H

HK$5.71

HK$851.96M

-7.27

40.23%

―

Genor Biopharma Holdings Limited

HK$3.06

HK$4.36B

2.00

-20.22%

―

TOT BIOPHARM International Co. Ltd.

HK$2.50

HK$3.38B

-16.22

142.21%

―

Zhaoke Ophthalmology Ltd.

HK$3.17

HK$1.47B

-4.01

8.68%

―

Immunotech Biopharm Ltd

HK$2.68

HK$518.70M

-3.95

-73.14%

―

Hightide Therapeutics Inc

HK$3.05

HK$1.76B

-2.75

19.30%

1 Buy

0 Hold

0 Sell

Moderate Buy

xxxxxxxxxxxxx

2185 vs 2511

xxxxxxxxxxxxx

Performance Comparison

HK:2185

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H

3.59

1.06

41.90%

HK:6998

Genor Biopharma Holdings Limited

2.13

-0.55

-20.52%

HK:1875

TOT BIOPHARM International Co. Ltd.

4.43

2.60

142.08%

HK:6622

Zhaoke Ophthalmology Ltd.

2.63

0.30

12.88%

HK:6978

Immunotech Biopharm Ltd

0.80

-2.35

-74.60%

HK:2511

Hightide Therapeutics Inc

3.40

0.65

23.64%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >